The Genetic Disorders of Mucociliary Clearance Consortium (GDMCC) is recruiting for a clinical study. The project is the R01 “Functional Studies of Novel Genes Mutated in Primary Ciliary Dyskinesia II: Genotype to Phenotype” mucociliary clearance study.
This project is focused specifically on recruiting subjects who have confirmed mutations in RSPH1.
Eligibility criteria, contact information, and more details available at: https://clinicaltrials.gov/ct2/show/NCT04901715.